Catalent
ApprovedProviding CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
Founded
2007
Focus
Drug Delivery
About
Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
Funding History
1Total raised: $870M
IPO$870MUndisclosedJul 31, 2014
FDA Approved Drugs
1CETIRIZINE HYDROCHLORIDE ALLERGYANDASep 21, 2020
Company Info
TypePrivate
Founded2007
LocationSomerset, Germany
StageApproved
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile